FDA updates guidance on using ventilator splitters
The Food and Drug Administration today issued on using ventilator splitters to support more than one patient when other options are unavailable.
FDA recommends health care providers limit ventilation sharing to two patients and 48 hours duration; try to match patients based on similar ventilatory requirements; reserve at least one single-patient ventilator for emergencies; and consider updated ventilator sharing protocols to minimize risk.
FDA last March emergency use of certain ventilators and ventilator accessories for treating patients during the COVID-19 pandemic to address observed and anticipated shortages of ventilators and ventilator accessories.
Related News Articles
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…